• Cat-intel
  • MedIntelliX
  • Consulting
  • Resources
  • About Us
  • News
  • Careers
  • Contact Us
  • Login
    • Hero Background

    Hemangioma Companies

    ID: MRFR/Pharma/2349-HCR
    200 Pages
    Kinjoll Dey
    October 2025

    Hemangiomas are benign tumors that develop from blood vessels, and they are typically found in the skin or internal organs. These tumors are common in infants, often appearing shortly after birth and then gradually resolving over time. In some cases, however, medical intervention may be necessary.

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Hemangioma Market Research Report - Forecast To 2035 Infographic
    Summary Table of Contents Segmentation Download PDF

    Top Industry Leaders in the Hemangioma Market

    Hemangioma Key Companies

     

    Latest Hemangioma Companies Update


    Candela medical device company offers various laser systems used for hemangioma treatment, and they continue to refine their technology and expand their reach in the market.


    MIR-819 Therapeutics company is developing a novel RNA interference therapy specifically targeting hemangiomas, currently in early clinical trials.


    Smaller companies and research institutions are actively exploring innovative treatment options and diagnostic tools for hemangiomas, adding to the overall momentum in the space.


    List of Hemangioma Key Companies in the Market



    • Akrimax Pharmaceuticals

    • LLC. (US)

    • AstraZeneca (UK)

    • Cutting Edge Laser Technologies (US)

    • Linline Medical Systems (France)

    • Novartis AG (Switzerland)

    • Pfizer Inc. (US)

    • Pierre Fabre (US

    • Quanta System S.p.A. (Italy)